Výsledky vyhledávání - "Veerdonk, F.L. van de"

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with Covid-19. A randomized clinical trial

Autor: Lawler, P.R., Derde, L.P.G., Veerdonk, F.L. van de, McVerry, B.J., Huang, D.T., Berry, L.R., Lorenzi, E., Kimmenade, R.R.J. van, Gommans, F., Vaduganathan, M., Leaf, D.E., Baron, R.M., Kim, E.Y., Frankfurter, C., Epelman, S., Kwan, Y., Grieve, R., O'Neill, S., Sadique, Z., Puskarich, M., Marshall, J.C., Higgins, A.M., Mouncey, P.R., Rowan, K.M., Al-Beidh, F., Annane, D., Arabi, Y.M., Au, C., Beane, A., Bentum-Puijk, W. van, Bonten, M.J.M., Bradbury, C.A., Brunkhorst, F.M., Burrell, A., Buzgau, A., Buxton, M., Cecconi, M., Cheng, A.C., Cove, M., Detry, M.A., Estcourt, L.J., Ezekowitz, J., Fitzgerald, M., Gattas, D., Godoy, L.C., Goossens, H., Haniffa, R., Harrison, D.A., Hills, T., Horvat, C.M., Ichihara, N., Lamontagne, F., Linstrum, K.M., McAuley, D.F., McGlothlin, A., McGuinness, S.P., McQuilten, Z., Murthy, S., Nichol, A.D., Owen, D.R.J., Parke, R.L., Parker, J.C., Pollock, K.M., Reyes, L.F., Saito, H., Santos, M.S., Saunders, C.T., Seymour, C.W., Shankar-Hari, M., Singh, V., Turgeon, A.F., Turner, A.M., Zarychanski, R., Green, C., Lewis, R.J., Angus, D.C., Berry, S., Gordon, A.C., McArthur, C.J., Webb, S.A.

Publikováno v: Lawler, P R, Derde, L P G, Van De Veerdonk, F L, McVerry, B J, Huang, D T, Berry, L R, Lorenzi, E, Van Kimmenade, R, Gommans, F, Vaduganathan, M, Leaf, D E, Baron, R M, Kim, E Y, Frankfurter, C, Epelmaņ, S, Kwan, Y, Grieve, R, O'Neill, S, Sadique, Z, Puskarich, M, Marshall, J C, Higgins, A M, Mouncey, P R, Rowan, K M, Al-Beidh, F, Annane, D, Arabi, Y M, Au, C, Beane, A, Van Bentum-Puijk, W, Bonten, M J M, Bradbury, C A, Brunkhorst, F M, Burrell, A, Buzgau, A, Buxton, M, Cecconi, M, Cheng, A C, Cove, M, Detry, M A, Estcourt, L J, Ezekowitz, J, Fitzgerald, M, Gattas, D, Godoy, L C, Goossens, H, Haniffa, R, Harrison, D A, Hills, T, Horvat, C M, Ichihara, N, Lamontagne, F, Linstrum, K M, McAuley, D F, McGlothlin, A, McGuinness, S P, McQuilten, Z, Murthy, S, Nichol, A D, Owen, D R J, Parke, R L, Parker, J C, Pollock, K M, Reyes, L F, Saito, H, Santos, M S, Saunders, C T, Seymour, C W, Shankar-Hari, M, Singh, V, Turgeon, A F, Turner, A M, Zarychanski, R, Green, C, Lewis, R J, Angus, D C, Berry, S, Gordon, A C, McArthur, C J & Webb, S A 2023, ' Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with Covid-19. A randomized clinical trial ', JAMA, vol. 329, no. 14, pp. 1183-1196 . https://doi.org/10.1001/jama.2023.4480
Jama : Journal of the American Medical Association, 329, 14, pp. 1183-1196
Jama : Journal of the American Medical Association, 329, 1183-1196

Contains fulltext : 291878.pdf (Publisher’s version ) (Closed access) IMPORTANCE: Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. OBJECTIVE: To determine whether angiotensin-c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8ff6a211c4c42dc02259195c83981b0d
https://pure.qub.ac.uk/en/publications/8cae3556-8039-49ea-a414-6da1b5a01052

Zobrazit plný text záznamu

Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands

Autor: Nooijer, A.H. de, Kooistra, E.J., Grondman, I., Janssen, N.A.F., Joosten, L.A.B., Veerdonk, F.L. van de, Kox, M., Pickkers, P., Netea, M.G.

Publikováno v: Clinical Obesity, 13, 2
Clinical Obesity, 13

Contains fulltext : 291401.pdf (Publisher’s version ) (Open Access) Obesity is recognized as a risk factor for adverse outcome in COVID-19, but the molecular mechanisms underlying this relationship remain unknown. Adipose tissue functions as an end

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::82124d492b062a54fcb95af7ed482b2f
https://hdl.handle.net/2066/291401

Zobrazit plný text záznamu

Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy

Autor: Grootveld, Rebecca van, Beek, M.T. van der, Janssen, N.A.F., Ergün, M., Dijk, Karin van, Bethlehem, Carina, Reijers, M.H.E., Bruggemann, R.J.M., Veerdonk, F.L. van de, Verweij, P.E., Schouten, J.A.

Publikováno v: Journal of Critical Care, 76

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::338262050baf2e83c4a56b217f5a2df9
http://hdl.handle.net/2066/293005

Zobrazit plný text záznamu

The Renin-Angiotensin System in Acute Lung Injury

Autor: Lawler, P.R., Derde, L.P.G., McVerry, B.J., Russell, James A., Veerdonk, F.L. van de

Publikováno v: Critical Care Medicine, 50, 9, pp. 1411-1415
Critical Care Medicine, 50, 1411-1415

Item does not contain fulltext

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::701e8639d941fc78e6fe791bff2d6a5e
https://doi.org/10.1097/CCM.0000000000005567

Zobrazit plný text záznamu

Host Genetic Signatures of Susceptibility to Fungal Disease

Autor: Campos, C.F., Veerdonk, F.L. van de, Goncalves, S.M., Cunha, C., Netea, M.G., Carvalho, A.

Publikováno v: Current Topics in Microbiology and Immunology, 422, pp. 237-263
Current Topics in Microbiology and Immunology, 422, 237-263

Contains fulltext : 208806.pdf (Author’s version preprint ) (Closed access) Our relative inability to predict the development of fungal disease and its clinical outcome raises fundamental questions about its actual pathogenesis. Several clinical ri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::90d450bd31bfb0bd7e140d058f0e7d27
https://doi.org/10.1007/82_2018_113

Zobrazit plný text záznamu

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Autor: Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., Bentum-Puijk, W. van, Berry, L.R., Bhimani, Z., Bonten, M.J.M., Bradbury, C.A., Brunkhorst, F.M., Buzgau, A., Cheng, A.C., Detry, M.A., Duffy, E.J., Estcourt, L.J., Fitzgerald, M., Goossens, H., Haniffa, R., Higgins, A.M., Hills, T.E., Horvat, C.M., Lamontagne, F., Lawler, P.R., Leavis, H.L., Linstrum, K.M., Litton, E., Lorenzi, E., Marshall, J.C., Mayr, F.B., McAuley, D.F., McGlothlin, A., McGuinness, S.P., McVerry, B.J., Montgomery, S.K., Morpeth, S.C., Murthy, S., Orr, K., Parke, R.L., Parker, J.C., Patanwala, A.E., Pettilä, V., Rademaker, E., Santos, M.S., Saunders, C.T., Seymour, C.W., Shankar-Hari, M., Sligl, W.I., Turgeon, A.F., Turner, A.M., Veerdonk, F.L. van de, Zarychanski, R., Green, C., Lewis, R.J., Angus, D.C., McArthur, C.J., Berry, S., Schouten, J.A., Pickkers, P., Webb, S.A., Derde, L.P.G.

Publikováno v: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2021, 384 (16), pp.1491-1502. ⟨10.1056/NEJMoa2100433⟩
McAuley, D & Writing Committee, REMAP-CAP 2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', New England Journal of Medicine . https://doi.org/10.1056/NEJMoa2100433
2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', New England Journal of Medicine, vol. 384, no. 16, pp. 1491-1502 . https://doi.org/10.1056/NEJMoa2100433
The New England Journal of Medicine, 384, 16, pp. 1491-1502
The New England Journal of Medicine, 384, 1491-1502
NEW ENGLAND JOURNAL OF MEDICINE
REMAP-CAP Investigators, Felton, T & Dark, P 2021, ' Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 ', The New England Journal of Medicine, vol. 384, no. 16, pp. 1491-1502 . https://doi.org/10.1056/NEJMoa2100433
The New England Journal of Medicine

BACKGROUNDThe efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.METHODSWe evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a842cc61a154327cc1bed7cc2b37f04
https://pubmed.ncbi.nlm.nih.gov/34920865

Zobrazit plný text záznamu

Treatment of ARDS and other parameters related to Covid-19

Autor: Netea, M.G., Deuren, M. van, Meer, H. van der, Veerdonk, F.L. van de, Mast, Q. de, Bruggemann, R.J.M., Hoeven, J.G. van der

Item does not contain fulltext

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::61cd67afb9f2dde1fdb07d79effdaf50
https://hdl.handle.net/2066/228267

Zobrazit plný text záznamu

[Medication and comedication in COVID-19 patients]

Autor: Lenkens, M., Wit, H. de, Danser, A.H., Esselink, A.C., Horikx, A., Oever, J. ten, Veerdonk, F.L. van de, Kramers, C.

Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 164

Item does not contain fulltext This paper discusses the possible effects of comedication on COVID-19 and the current treatment options for this infection. It is very doubtful that comedication has a disadvantageous effect on the course of the disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4f08bc5ab5dd87e33967a116b0f0dc50
https://hdl.handle.net/2066/220362

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání